HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Canadian Rx-to-OTC Approval Process Could Be Smoother, GSK Exec Says

This article was originally published in The Tan Sheet

Executive Summary

Canada's Rx-to-OTC switch process should be streamlined and made more industry-friendly, according to GlaxoSmithKline regulatory executive Jennifer Denomme

You may also be interested in...

Applying Drug Model To Regulating Canada’s Supplements Sparks Opposition

A proposed amendment to Canada's Food and Drugs Act could move the regulation of natural health products closer to the pharmaceutical regulatory model, according to the Canadian Health Food Association

NDMAC Urges OTC Exclusivity In Canada Similar To U.S. Model

Canadian regulators should allow three-year exclusivity for innovations in both existing and new nonprescription drug products, the country's self-care industry trade group says

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts